Home FDA labels 669a0245-d995-4e93-8d10-d01dec029b0b K Phos Neutral openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name K Phos Neutral
Generic name SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Manufacturer Beach Products, Inc.
Product type HUMAN PRESCRIPTION DRUG
SPL set ID 83376725-ee0f-40ad-bd90-31a61b9445cf
SPL ID 669a0245-d995-4e93-8d10-d01dec029b0b
Version 6
Effective date 2023-02-23
Source export date 2026-10-12
Source partition 11
Source file https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 02:44:41 Harmonized routes table Harmonized routes ORAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 15 matching rows.
Type, Scope, Identifier table Type Scope Identifier Source field brand name K Phos Neutral openfda.brand_name generic name SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE openfda.generic_name manufacturer name Beach Products, Inc. openfda.manufacturer_name ndc package 0486-1125-01 openfda.package_ndc ndc package 0486-1125-05 openfda.package_ndc ndc product 0486-1125 openfda.product_ndc ndc11 package 00486112505 derived:openfda.package_ndc ndc11 package 00486112501 derived:openfda.package_ndc rxcui 200251 openfda.rxcui rxcui 1251241 openfda.rxcui spl id 669a0245-d995-4e93-8d10-d01dec029b0b id spl set id 83376725-ee0f-40ad-bd90-31a61b9445cf set_id unii 22ADO53M6F openfda.unii unii 4J9FJ0HL51 openfda.unii unii 593YOG76RN openfda.unii
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS Gastrointestinal upset (diarrhea, nausea, stomach pain and vomiting) may occur with phosphate therapy. Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur. The following adverse effects may be observed (primarily from sodium or potassium): headaches; dizziness; mental confusion; seizures; weakness or heaviness of legs; unusual tiredness or weakness; muscle cramps; numbness, tingling, pain, or weakness of hands or feet; numbness or tingling around lips; fast or irregular heartbeat; shortness of breath or troubled breathing; swelling of feet or lower legs; unusual weight gain; low urine output; unusual thirst.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.